Wildlife Service

Wildlife is a biotechnology company pioneering an evolutionary-scale approach to drug discovery. By leveraging artificial intelligence and large-scale genomic data from diverse species across the natural world, the company identifies novel therapeutic targets and biological insights that are often missed by traditional human-centric research. Wildlife's platform maps these evolutionary 'experiments' to human disease biology to accelerate the development of transformative medicines. Founded by industry veterans from AstraZeneca and the Broad Institute, the company is backed by leading investors including GV and F-Prime Capital.